Fisher Asset Management LLC Sells 285,053 Shares of Haleon plc (NYSE:HLN)

Fisher Asset Management LLC lessened its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 2.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,682,262 shares of the company's stock after selling 285,053 shares during the period. Fisher Asset Management LLC owned 0.30% of Haleon worth $144,758,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. O Shaughnessy Asset Management LLC increased its position in shares of Haleon by 94.0% in the first quarter. O Shaughnessy Asset Management LLC now owns 43,766 shares of the company's stock worth $372,000 after purchasing an additional 21,202 shares during the period. 1832 Asset Management L.P. raised its position in shares of Haleon by 6.3% in the 1st quarter. 1832 Asset Management L.P. now owns 98,510 shares of the company's stock valued at $836,000 after buying an additional 5,795 shares in the last quarter. Bayesian Capital Management LP acquired a new position in shares of Haleon in the 1st quarter valued at approximately $645,000. Dynasty Wealth Management LLC bought a new stake in shares of Haleon during the 1st quarter worth approximately $692,000. Finally, B. Riley Wealth Advisors Inc. boosted its position in shares of Haleon by 23.2% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 29,324 shares of the company's stock worth $246,000 after acquiring an additional 5,519 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Trading Up 0.1 %

Shares of NYSE:HLN traded up $0.01 during midday trading on Tuesday, hitting $9.59. 4,856,842 shares of the stock were exchanged, compared to its average volume of 5,312,145. The business's 50-day moving average price is $9.99 and its 200 day moving average price is $9.40. Haleon plc has a 12 month low of $7.89 and a 12 month high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a market capitalization of $43.41 billion, a price-to-earnings ratio of 28.12, a P/E/G ratio of 2.91 and a beta of 0.30.

Wall Street Analysts Forecast Growth

HLN has been the subject of a number of research analyst reports. Berenberg Bank began coverage on Haleon in a research report on Tuesday, August 6th. They set a "buy" rating for the company. UBS Group upgraded shares of Haleon to a "strong-buy" rating in a research note on Tuesday, October 1st. The Goldman Sachs Group lowered shares of Haleon from a "buy" rating to a "neutral" rating in a report on Tuesday, August 6th. Finally, Morgan Stanley raised their target price on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.